Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine

The Journal of Surgical Research
Thiruma V ArumugamStephen M Taylor

Abstract

The complement system is a major contributor to the pathogenesis of intestinal ischemia-reperfusion (I/R) injury. We have studied the action of an orally active complement factor 5a (C5a) receptor antagonist, the cyclic peptide AcF-(OPdChaWR) [Ac-Phe(Orn-Pro-d-cyclohexylalanine-Trp-Arg)] against local and remote intestinal I/R injuries in rats. Anesthetized rats were administered with AcF-(OPdChaWR) at doses of 1 mg/kg intravenously or 0.3, 1, or 10 mg/kg orally with pyrogen-free saline for sham control animals. The superior mesenteric artery was occluded for 30 min and the intestine reperfused for 120 min. Changes associated with tissue injury were assessed by neutropenia, intestinal edema, serum tumor necrosis factor-alpha, serum haptoglobin, plasma aspartate aminotransferase, and histopathology. Pretreatment with either a single intravenous dose (1 mg/kg), or a single oral dose (10 mg/kg) of AcF-(OPdChaWR) significantly inhibited I/R induced neutropenia, the elevated serum levels of tumor necrosis factor-alpha, haptoglobin, and plasma aspartate aminotransferase, as well as intestinal edema. Histological analysis of AcF-(OPdChaWR)-treated I/R animals showed markedly reduced mucosal layer damage compared to that of untreated r...Continue Reading

References

Jan 1, 1988·Veterinary Research Communications·P D Eckersall, J G Conner
Jan 31, 1989·Biochemical and Biophysical Research Communications·J FilepT Mózes
Dec 1, 1994·Journal of Leukocyte Biology·J A Smith
Jul 1, 1994·The Journal of Surgical Research·A C SisleyB L Gewertz
May 1, 1993·The Journal of Surgical Research·K KoikeA Banerjee
Mar 6, 1999·Journal of Applied Physiology·J P WilliamsH B Hechtman
Mar 18, 1999·Clinical Immunology : the Official Journal of the Clinical Immunology Society·A T ErorT Shea-Donohue
Apr 3, 1999·British Journal of Pharmacology·A ShortS M Taylor
Jul 28, 1999·Critical Reviews in Immunology·B P Morgan
Dec 22, 1999·British Journal of Pharmacology·N J PaczkowskiS M Taylor
Apr 25, 2000·Annual Review of Medicine·K A Papadakis, S R Targan
Jul 6, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·A J SzalaiJ E Volanakis
Aug 11, 2000·Chest·C A Dinarello

❮ Previous
Next ❯

Citations

Mar 29, 2011·Molecular Pharmacology·Hariharan SubramanianHydar Ali
Mar 18, 2005·Annual Review of Immunology·Ren-Feng Guo, Peter A Ward
Oct 24, 2006·Journal of Biomedicine & Biotechnology·Lei SunPeter A Ward
Sep 18, 2007·Immunologic Research·Pieter-Jan Haas, Jos van Strijp
Jun 30, 2009·The Tohoku Journal of Experimental Medicine·Orhan Veli OzkanNizami Duran
Jan 21, 2004·The Journal of Surgical Research·Trent M WoodruffStephen M Taylor
Nov 19, 2015·Microbiology and Immunology·Eszter TubolyHidechika Okada
Dec 11, 2002·Kidney International·Thiruma V ArumugamStephen M Taylor
May 10, 2011·Molecular Immunology·Trent M WoodruffFrancesco Tedesco
Jan 28, 2003·The American Journal of Pathology·Gregory L StahlHui Zhao
Jul 22, 2008·The Journal of Surgical Research·Sherry D FlemingGeorge C Tsokos
Mar 14, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Michael MorganIan A Shiels
Apr 10, 2007·Biochemical and Biophysical Research Communications·Haimou ZhangDong-Xu Liu
Jul 3, 2007·British Journal of Pharmacology·P N MonkD P Fairlie
Aug 15, 2006·Molecular Immunology·Bo NilssonJohn D Lambris
Jun 20, 2006·International Immunopharmacology·Lavinia M ProctorStephen M Taylor
Jul 29, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Thiruma V ArumugamStephen M Taylor
Jul 14, 2005·Molecular Immunology·Tom E Mollnes, Michael Kirschfink
Jun 28, 2005·Annals of Vascular Surgery·John B Seal, Bruce L Gewertz
Jan 27, 2012·The Veterinary Journal·M N M HezmeeP C Mills
Jun 1, 2013·Seminars in Immunology·Ke Li, Wuding Zhou
Nov 16, 2004·Lancet·Norberto PericoGiuseppe Remuzzi
Jan 27, 2006·World Journal of Gastroenterology : WJG·Ismail H MallickAlexander M Seifalian
Sep 21, 2004·Microsurgery·Maria Siemionow, Emrah Arslan
Dec 29, 2007·Journal of Pediatric Gastroenterology and Nutrition·Hale SayanS Oktay Arslan
Apr 24, 2019·Aging and Disease·Yuanyuan MaGuo-Yuan Yang
Oct 4, 2013·Shock·Zoe Victoria SchofieldMatthew Allister Cooper
May 10, 2005·The Journal of Pharmacology and Experimental Therapeutics·Trent M WoodruffStephen M Taylor
May 2, 2009·Plastic and Reconstructive Surgery·Soner H TatlidedeWilliam G Austen
Jul 15, 2011·Journal of Cardiovascular Pharmacology·Abishek IyerLindsay Brown
Apr 17, 2004·Shock·Thiruma V ArumugamStephen M Taylor
Mar 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Koei YamadaWen-Chao Song
May 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Melanie L HartGregory L Stahl
Sep 20, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hao WangRussell P Rother

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.